Good binocular results in children with early-onset exotropia

Article

The surgical outcomes for children treated for constant early-onset exotropia demonstrated good binocular results, claims a study in the journal Eye.

The surgical outcomes for children treated for constant early-onset exotropia demonstrated good binocular results, claims a study in the journal Eye.

A research team led by Dr S. Y. Suh, Department of Ophthalmology, Seoul National University College of Medicine, Seoul, Korea, examined the medical records of 45 exotropia patients with a reported onset before one year of age. All patients were operated on between 2008 and 2011 and clinical characteristics and surgical outcomes were analysed retrospectively.

Patients were divided into either a constant exotropia group (XT) or and intermittent group (X(T)). The team compared clinical features and surgical results of exotropia between the two groups. The mean age at surgery was 4.5±2.4 years and the mean postoperative follow-up period was 17.3 months.

Of the total patients reviewed, 67% demonstrated an alignment of less than ±10 prism diopters (PD) at the final visit. In all 34 testable patients, gross stereopsis was achieved and bifixation was developed in 10 patients. There were no significant differences between the groups with regards to surgical success rates and binocularities.

Both motor and sensory surgical outcomes were not poor in early-onset exotropia patients, even in those with constant deviation.

The abstract can be read here.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.